SCN8A epileptic encephalopathy: literature review and own observation
Open Access
- 13 October 2023
- journal article
- research article
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 4 (3) , 165-174
Abstract
A genetic disease caused by pathogenetic nucleotide variants in the SCN8A gene (Sodium channel protein type 8 subunit alpha, also known as Nav1.6), encoding the α-subunit of the Na channel type 8, is included in the group of early epileptic encephalopathies. In most cases, this pathology is characterized by the development of polymorphic pharmacoresistant epileptic seizures over the first year of a child’s life, a lag in psychomotor development or regression, loss of skills. In some patients, seizures may appear during the first days of life, while in others they appear later (at the age of 2 to 7 months), against the background of a pronounced or slight developmental delay. Types of seizures may include generalized, tonic-clonic seizures, infantile spasms, absences and focal seizures. Other signs and symptoms of encephalopathy caused by mutations of the SCN8A gene may include low muscle tone (hypotension), high pain threshold, motor disorders (such as dystonia and ataxia), mild to severe mental retardation, sleep problems and autistic traits. In some people with SCN8A encephalopathy, various other pathological changes in the body have been reported, including hearing or vision impairment, scoliosis, and thermoregulation difficulties. The disease is inherited by an autosomal dominant type. To date, the disease in the OMIM system is referred to as «Developmental encephalopathy and epileptic encephalopathy type 13». Previously, the disease was called «Early infantile (infantile) epileptic encephalopathy, type 13». The serial number «13» indicates this form of early epileptic encephalopathy to be caused by a heterozygous mutation in the gene on the long arm of chromosome 12 in chromosome region 12q13.13. This report also presents a clinical description of a patient suffering from early infantile epileptic encephalopathy, type 13.Keywords
This publication has 15 references indexed in Scilit:
- Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological ApproachNeurotherapeutics, 2015
- SCN8A mutations in Chinese children with early onset epilepsy and intellectual disabilityEpilepsia, 2015
- De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsyJournal of Medical Genetics, 2015
- Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathyEpilepsy Research, 2014
- A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathyNeurobiology of Disease, 2014
- Whole‐exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective studyClinical Genetics, 2014
- Early onset epileptic encephalopathy caused by de novo SCN8A mutationsEpilepsia, 2014
- De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEPThe American Journal of Human Genetics, 2012
- Unusual consequences of status epilepticus in Dravet syndromeSeizure: European Journal of Epilepsy, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010